Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Otitis media: the chinchilla model.

G S Giebink1

  • 1Otitis Media Research Center, University of Minnesota School of Medicine, Minneapolis 55455, USA.

Microbial Drug Resistance (Larchmont, N.Y.)
|May 20, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microdialysis studies of the middle ear distribution kinetics of amoxicillin in the awake chinchilla.

Journal of pharmaceutical sciences·2001
Same author

A multi-laboratory evaluation of an enzyme-linked immunoassay quantitating human antibodies to Streptococcus pneumoniae polysaccharides.

Immunological investigations·2001
Same author

Low cord blood pneumococcal antibody concentrations predict more episodes of otitis media.

Archives of otolaryngology--head & neck surgery·2001
Same author

Otitis media prevention: non-vaccine prophylaxis.

Vaccine·2001
Same author

Low cord blood type 14 pneumococcal IgG1 but not IgG2 antibody predicts early infant otitis media.

The Journal of infectious diseases·2000
Same author

An analytical model applied to a multicenter pneumococcal enzyme-linked immunosorbent assay study.

Journal of clinical microbiology·2000
Same journal

Trends, Patterns, and Demographic Dynamics of Drug Resistance in <i>Mycobacterium tuberculosis</i> and Nontuberculous: A Multi-Year Analysis at the National Tuberculosis Reference Laboratory.

Microbial drug resistance (Larchmont, N.Y.)·2026
Same journal

Ceftazidime-Avibactam/Colistin Combination Against Carbapenem-Resistant <i>Pseudomonas aeruginosa: In Vitro</i> Synergy Indicating a Possible Therapeutic Approach.

Microbial drug resistance (Larchmont, N.Y.)·2026
Same journal

Rapid Screening of <i>Klebsiella pneumoniae</i> Isolates Reveals Multidrug-Resistant and Virulence Traits in a Tertiary Level Hospital in Panama.

Microbial drug resistance (Larchmont, N.Y.)·2026
Same journal

Clinical Characteristics and Genomic Analysis of Vancomycin-Resistant <i>Enterococcus faecium</i> in a Tertiary Hospital in Huizhou.

Microbial drug resistance (Larchmont, N.Y.)·2026
Same journal

Burden of Carbapenemase-Producing Enterobacterales in Critical Care Settings: Insights from a Tunisian Intensive Care Unit.

Microbial drug resistance (Larchmont, N.Y.)·2026
Same journal

Distribution of Tetracycline and β-Lactam Resistance Genes in the Oropharyngeal and Anorectal Mucosa of Men Who Have Sex with Men: An Exploratory Study.

Microbial drug resistance (Larchmont, N.Y.)·2026
See all related articles

The chinchilla model offers a unique approach to studying Streptococcus pneumoniae infections, particularly middle ear infections. This model aids in understanding disease pathogenesis, vaccine efficacy, and antimicrobial drug effectiveness.

Area of Science:

  • Microbiology
  • Immunology
  • Otolaryngology

Background:

  • Streptococcus pneumoniae infections are a significant global health concern, leading to various diseases including otitis media.
  • Animal models are crucial for studying pneumococcal pathogenesis, vaccine development, and antimicrobial efficacy.
  • Existing models often focus on sepsis, with fewer options for studying localized mucosal infections like otitis media.

Purpose of the Study:

  • To highlight the utility of the chinchilla model for investigating Streptococcus pneumoniae infections, specifically otitis media.
  • To detail the applications of this model in understanding pathogenesis, immune responses, and treatment strategies.
  • To underscore the model's unique advantages for studying mucosal infections.

Main Methods:

Related Experiment Videos

  • Utilizing the chinchilla model for intranasal and middle ear inoculation of Streptococcus pneumoniae.
  • Investigating pneumococcal virulence factors, host inflammatory responses, and the impact of coinfections (e.g., influenza A virus).
  • Evaluating the immunogenicity and efficacy of pneumococcal capsular polysaccharide (PS) vaccines and antimicrobial drugs.

    • Main Results:

    • The chinchilla model accurately replicates middle ear infections, allowing for localized disease study.
    • Demonstrated variation in virulence among pneumococcal serotypes and the exacerbating effect of influenza A virus.
    • Showcased the effectiveness of PS vaccines and the development of rational antimicrobial dosing strategies.

    Conclusions:

    • The chinchilla model is invaluable for studying pneumococcal otitis media pathogenesis, host-pathogen interactions, and the efficacy of interventions.
    • This model facilitates research into vaccine development and the rational use of antimicrobial drugs for middle ear infections.
    • Findings from this model contribute to a better understanding and management of Streptococcus pneumoniae-related diseases.